SNP 7/8a
Alternative Names: SNAP cancer vaccine; SNAP CV - Avidea Technologies; SNAP-CV; SNP-7/8aLatest Information Update: 28 Dec 2024
Price :
$50 *
At a glance
- Originator Avidea
- Developer Avidea; GenScript Biotech Corp; Vaccine Research Center
- Class Antineoplastics; Cancer vaccines; Peptide vaccines
- Mechanism of Action Immunostimulants; T lymphocyte stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Cancer
Most Recent Events
- 28 Dec 2024 No recent reports of development identified for preclinical development in Cancer in USA (IV)
- 28 Dec 2024 No recent reports of development identified for preclinical development in Cancer in USA (SC)
- 13 Dec 2021 Avidea Technolgies has been acquired by Vaccitech